INSM logo

Insmed Inc (INSM)

Insmed Incorporated develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally. The company offers ARIKAYCE for the treatment of refractory nontuberculous mycobacterial lung infections, as well as is in phase 3 clinical trial for the treatment of mycobacterium avium complex lung...

NASDAQHealthcareBiotechnologyUSA

Company Profile

Stock Code
INSM
ISIN Code
US4576693075
Currency
US Dollar (USD)
IPO Date
2000-06-01

Contact Information

Company Address
700 US Highway 202/206, Bridgewater, NJ, United States, 08807
Contact Phone
908 977 9900
Company Website
https://www.insmed.com
Fiscal Year End
December

Financial Highlights

Market Capitalization
$999,999.99
Gross Profit (TTM)
$999,999.99
Return on Assets (TTM)
-31.11%
EBITDA
$-999,999.99
Revenue (TTM)
$999,999.99